O. S. Breathnach, MDa, D. J. Kwiatkowski, MD, PhDb, D. M

Slides:

Advertisements

Similar presentations

The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications Jih-Shiuan Wang, MD, Dominique.

Advertisements

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Lung cancer screening: No more excuses

Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD

The days of future past Neel K. Ranganath, MD, Aubrey C. Galloway, MD

Thoracoscopic management of postoperative esophageal leak

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Ground glass opacity of the lung: The veil that needs lifting

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Victor van Berkel, MD, PhD

Multilevel data analysis: What? Why? How?

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

Go on-pump or off-pump in diabetic patients?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

An economic evaluation of lung transplantation

The lord of the rings Antonio Miceli, MD, PhD

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Segmentectomy for selected cT1N0M0 non–small cell lung cancer: A prospective study at a single institute Hiroaki Nomori, PhD, Takeshi Mori, PhD, Koei.

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Occult active giant cell aortitis necessitating surgical repair

Support Your Specialty

It's not “just a shunt” but sometimes it should be…

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Confusion still exists regarding postoperative delirium and its etiology after esophagectomy Robert B. Cameron, MD The Journal of Thoracic and Cardiovascular.

Stephen R. Broderick, MD, MPHS

Navigating the lung for hidden treasure

Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classification Jacek Jassem, MDa, Jan.

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Yusuke Takahashi, MD, PhD, Prasad S. Adusumilli, MD

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

The Ross procedure: Time to reevaluate the guidelines

The α folate receptor is highly activated in malignant pleural mesothelioma Raphael Bueno, MDa, Krishnarao Appasani, PhDa, Harriet Mercer, BSa, Susan.

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Carcinoma of the esophagus: Prognostic significance of histologic type

Prognosis and “granularity”: Building on staging foundations?

Functional tricuspid pathology: To treat or not to treat

Problems related to TNM staging: Patients with stage III non–small cell lung cancer Kotaro Kameyama, MD, Cheng-long Huang, MD, Dage Liu, MD, Taku Okamoto,

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Keep it short and sweet Ian A. Makey, MD, Scott B. Johnson, MD

Tai Ji: The law of inflammatory response

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Neal S Goldstein, MD The Annals of Thoracic Surgery

The continuing challenge of congenital heart disease in China

Building a clinical program in a single institution

Therapeutic R2 resection for pleural mesothelioma

“The more things change…”: The challenges ahead

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

How do we follow up our patients

Pulmonary transplantation for advanced bronchioloalveolar carcinoma

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Presentation transcript:

Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease O.S. Breathnach, MDa, D.J. Kwiatkowski, MD, PhDb, D.M. Finkelstein, PhD c, J. Godleski, MD d, D.J. Sugarbaker, MD e, B.E. Johnson, MD a, S. Mentzer, MD, PhD e The Journal of Thoracic and Cardiovascular Surgery Volume 121, Issue 1, Pages 42-47 (January 2001) DOI: 10.1067/mtc.2001.110190 Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

Fig. 1 Postoperative survival in patients with pathologic stage I BAC compared with patients with stage I adenocarcinoma other than BAC (5-year survival: 83% vs 63%, respectively; P = .04). Circular marks represent censored data (●, BAC; ○, adenocarcinoma). The Journal of Thoracic and Cardiovascular Surgery 2001 121, 42-47DOI: (10.1067/mtc.2001.110190) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions